How long does reconstituted tirzepatide last?
Reconstituted tirzepatide in bacteriostatic water is typically referenced to a 28-day in-use stability window when stored refrigerated at 2-8 °C. The figure aligns with the antimicrobial protection profile of the preservative and the peptide’s chemical-degradation behaviour in aqueous solution.
What the research literature says
The 28-day in-use stability window for reconstituted tirzepatide tracks the same framework as the closely-related semaglutide and the broader long-acting peptide-therapeutic class. The bacteriostatic-water preservative provides multi-week antimicrobial coverage; the peptide’s intrinsic chemical stability is supported by the fatty-acid sidechain (which mediates albumin binding in circulation and incidentally contributes to in-vial solution stability) and the engineered backbone modifications that confer protease resistance.
The compound’s in-circulation pharmacokinetic profile — ~5-day plasma half-life, once-weekly dosing across the SURPASS and SURMOUNT clinical-trial programs (PMID 32730231, PMID 34170647) — speaks to the molecule’s intrinsic resistance to degradation. In-vial stability under refrigerated storage tracks the same intrinsic stability, with the practical 28-day threshold set conservatively to align with the preservative profile.
Frozen-aliquot storage extends functional shelf life beyond the refrigerated window when experimental protocols span multiple months. Standard aliquoting practice — dispense the reconstituted stock into single-use low-protein-binding microcentrifuge tubes, freeze, thaw one aliquot per experimental session — is documented in the peptide storage guide.
Why this matters in research context
Most tirzepatide research protocols mirror the clinical dose-titration pattern with weekly subcutaneous administration across multi-week dose-escalation periods. A typical 16-24 week protocol exceeds the 28-day refrigerated in-use window by 4-5x, which means either upfront aliquoting at reconstitution or mid-experiment re-reconstitution. The aliquot-and-freeze approach is the standard pick because it preserves single-batch consistency across the full experimental run.
Related compounds
- Tirzepatide 10mg — the compound covered by this answer
- Semaglutide 10mg — parallel long-acting incretin agonist with similar stability framework
Related research questions
- How much bacteriostatic water with tirzepatide?
- What is the half-life of tirzepatide?
- How long does reconstituted semaglutide last?
References
- Willard FS et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight 2020;5(17):e140532. [PMID 32730231]
- Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med 2021;385(6):503-515. [PMID 34170647]
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 2000;203(1-2):1-60. [PMID 10967427]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Tirzepatide is sold strictly as a research-grade reagent for laboratory and bench research applications.